🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Covid-19 in Hematological Malignancies

Recruitingn/aAges 18 Years - 99 YearsAllSorveglianza Epidemiologica Infezioni Fungine Emo…
NCT04733729 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The overall purpose of this project is to better understand the epidemiology of COVID-19 in patients with hematological malignancies (including hematopoietic stem cell transplant recipients) in the different European Countries. The results obtained will allow us to better know the prevalence of this complication in the different categories of patients with hematological malignancies (HMs). In order to attain the objectives previously described we will develop a multicentre, international, observational, retrospective and prospective study of consecutive cases of COVID-19 among HMs. There will be a clinical follow-up of the patients included in this study to observe the survival rate. Data collected form this study will be evaluated with a descriptive analysis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age equal to or greater than 18 years of age. * History of hematological malignancies (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status. * Active hematological malignancies at any stage/status. * Diagnosis of hematological malignancy (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status. * SARS-CoV-2 positive test (nasopharyngeal, BAL, fecal), documented by Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panels. Exclusion Criteria: * Hematological diseases, other than hematological malignancies. * Not tested positive for SARS-CoV-2 * Patients "off therapy" for more than 5 years
💊

What it tests

  • Not listed
📍

Where

6 sites
ASST-Spedali Civili
Brescia, Italy
AOU Policlinico Federico II
Naples, Italy
Fondazione Policlinico A. Gemelli IRCCS
Rome, Italy
Istituto Nazionale Tumori Regina Elena IFO
Rome, Italy
Osp. di Circolo-Fondazione Macchi
Varese, Italy
AOUI Verona
Verona, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy